Loading clinical trials...
Loading clinical trials...
Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed
The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.
To register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC. In this surgical intervention, the abdominal cavity is macroscopically cleared of tumor, by removing all visible tumor nodules, and is subsequently rinsed with hyperthermic (heated) chemotherapy, aiming to destroy all residual invisible tumor cells that might have stayed behind after the debulking. The eventual aim of this procedure is to improve the prognosis/survival of patients with malignancies localized on the peritoneal surface.
Age
All ages
Sex
ALL
Healthy Volunteers
No
University Clinics Gasthuisberg
Leuven, Flemish Brabant, Belgium
Start Date
May 1, 2012
Primary Completion Date
December 1, 2028
Completion Date
December 1, 2028
Last Updated
June 26, 2024
125
ESTIMATED participants
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
NCT07001748
NCT06511037
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions